QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Donald Gravenor who wrote (79)	2/14/1997 10:31:00 PM
From: Joe Stephenson	of 1321

If you are saying that the only use for Photofrin is for late stage lung cancer(paliative treatment)only, then why did the UBS Securities Report (Sept. '96) and QLT's most recent News Release (Feb. 11, '97) both state that Photofrin's use for Non Small Cell Lung Cancers is for both some early and late stage treatments. The News Release states "They show PHOTOFRIN(R)to be promising in treating certain early and late-stage lung cancers," Dr. Levy says. Later on the Release also states "In those patients with early-stage superficial lung cancer, results from three single arm studies showed PHOTOFRIN(R)PDT to provide durable complete tumor responses while preserving normal lung tissue." Am I missing something here, or doesn't this mean there should be a lung cancer market for Photofrin other than extending a life by a few weeks? I would appreciate your thoughts. I still agree however, that the BPD market for AMD is potentially huge. Also, you mentioned earlier about rumors that CIBAvision may be looking at QLT. Can you point me to any references on this one? Thanks.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next